RNA-seq of the Eμ-Myc transgenic mouse model of Burkitt lymphoma (34) and the EμSRα-tTA/tet-O-MYC model of T-ALL (70) highlighted changes to the expression of several glycogenes upon MYC-driven leukemia and lymphoma development (Fig. 3H). The gene discussed is MYC; the disease is Burkitt lymphoma.